Jorge Boán

6PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Medical infection agents (incl. prions)Cardiology (incl. cardiovascular diseases)Medical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 11, 2026
Randomized double-blind clinical trial evaluating the effectiveness and safety of secondary prophylaxis with oral vancomycin versus placebo in the prevention of recurrence of clostridioides difficile infection in patients receiving systemic antibiotic therapy (PREVAN trial).

Rafael San-Juan, Julia Origüen, Mario Fernández-Ruiz

|Feb 20, 2026
Rezafungin for Salvage or Consolidation Therapy of Invasive Fungal Disease: Experience in Real-World Clinical Practice.

Jorge Boán, Eduardo Aparicio-Minguijón, Mario Fernández-Ruiz

|Dec 24, 2025
The Unnoticed Threat: Clinical Characteristics, Risk Factors, and Outcome of Mucormycosis in Solid Organ Transplantation.

Jorge Boán, Mario Fernández-Ruiz, Eduardo Aparicio-Minguijón

|Dec 01, 2025
Skin and Soft Tissue Mucormycosis in Patients Receiving Bruton Tyrosine Kinase Inhibitors: Case Report and Literature Review.

Eduardo Aparicio-Minguijón, Nieves López-Muñoz, Jorge Boán

|May 28, 2025
[Impact of a dedicated multidisciplinary committee (endocarditis team) on the management and outcome of infective endocarditis in a reference center].

Javier Iglesias-Varea, Mario Fernández-Ruiz, Laura Domínguez

|Feb 07, 2025
Breakthrough Invasive Mold Infections in Hematologic Cases: Relevance of the Host's Factors.

Isabel Rodríguez-Goncer, Jorge Boán, Riansares Carrero-Arribas

Pageof 1

Frequent Collaborators

6 joint publications

Mario Fernández-Ruiz

5 joint publications

José María Aguado

5 joint publications

Eduardo Aparicio-Minguijón

4 joint publications

Francisco López-Medrano